Federal · 119th Congress
Biosimilars Access and Affordability Act
Policy areaHealth
The Congressional Research Service has not published a summary of this measure.
Read the text of the bill →Sponsor
Cosponsors9
Jake AuchinclossDU.S. Representative · 4th District · MA
John JoyceRU.S. Representative · 13th District · PA
Nathaniel MoranRU.S. Representative · 1st District · TX
Kevin MullinDU.S. Representative · 15th District · CA
Jimmy PanettaDU.S. Representative · 19th District · CA
Scott H. PetersDU.S. Representative · 50th District · CA
Linda T. SánchezDU.S. Representative · 38th District · CA
Rudy Yakym IIIRU.S. Representative · 2nd District · IN
Donald G. DavisDU.S. Representative · 1st District · NCOther titles2
To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.Official Title as Introduced
Biosimilars Access and Affordability ActShort Title(s) as Introduced
Legislative history3
Sep 28, 2026
HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 28, 2026
HouseReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 28, 2026
IntroducedIntroduced in House